P.5.a.005 An open label study of mirtazapine in the treatment of depression with Alzheimer's disease

An open-label study of escitalopram (Lexapro®) for the treatment of ‘Depression of Alzheimer's disease’ (dAD)

International Journal of Geriatric Psychiatry ◽

10.1002/gps.1459 ◽

2006 ◽

Vol 21 (3) ◽

pp. 273-274 ◽

Cited By ~ 18

Author(s):

V. Rao ◽

J. R. Spiro ◽

P. B. Rosenberg ◽

H. B. Lee ◽

A. Rosenblatt ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Treatment Of Depression

Get full-text (via PubEx)

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.859 ◽

2003 ◽

Vol 18 (6) ◽

pp. 549-551 ◽

Cited By ~ 42

Author(s):

V. P. Prasher ◽

C. Adams ◽

R. Holder ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Get full-text (via PubEx)

Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study

The American Journal of Geriatric Pharmacotherapy ◽

10.1016/s1543-5946(05)80020-0 ◽

2005 ◽

Vol 3 (3) ◽

pp. 137-148 ◽

Cited By ~ 63

Author(s):

Jeffrey L. Cummings ◽

Barbara Koumaras ◽

Michael Chen ◽

Dario Mirski

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Nursing Home ◽

Nursing Home Residents ◽

Open Label ◽

Behavioral Disturbances ◽

Open Label Study ◽

Label Study

Get full-text (via PubEx)

Brain stimulation by pulsed electromagnetic fields in the treatment of Alzheimer's disease: An open-label study

European Journal of Integrative Medicine ◽

10.1016/j.eujim.2016.08.015 ◽

2016 ◽

Vol 8 ◽

pp. 5-6

Author(s):

Fabio Guerriero ◽

Piero Mannu ◽

Gianni Mele ◽

Zoncu D ◽

Lorenzo Polo ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Electromagnetic Fields ◽

Brain Stimulation ◽

Pulsed Electromagnetic Fields ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Pulsed Electromagnetic

Get full-text (via PubEx)

A 52-week open-label study to investigate tolerability of rivastigmine switching from oral capsule to transdermal patch in mild to moderate Alzheimer’s disease patients in Taiwan

Journal of the Neurological Sciences ◽

10.1016/j.jns.2017.08.2909 ◽

2017 ◽

Vol 381 ◽

pp. 1030-1031

Author(s):

J.L. Fuh ◽

T.F. Chen ◽

T.H. Lan ◽

Y.W. Yang ◽

C.F. Tsai ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Transdermal Patch ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Oral Capsule

Get full-text (via PubEx)

Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine

Geriatrics and Gerontology International ◽

10.1111/ggi.12754 ◽

2016 ◽

Vol 17 (3) ◽

pp. 494-499 ◽

Cited By ~ 3

Author(s):

Soo J Yoon ◽

Seong H Choi ◽

Hae R Na ◽

Kyung-Won Park ◽

Eun-Joo Kim ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Combination Therapy ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Rivastigmine Patch

Get full-text (via PubEx)

PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer's Disease/Dementia Cohort

American Journal of Geriatric Psychiatry ◽

10.1016/j.jagp.2014.12.170 ◽

2015 ◽

Vol 23 (3) ◽

pp. S163-S164

Author(s):

Rachelle S. Doody ◽

Stephen D'Amico ◽

Andrew J. Cutler ◽

Paul Shin ◽

Frederic Ledon ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Traumatic Brain Injury ◽

Brain Injury ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Pseudobulbar Affect ◽

Alzheimer’S Disease Dementia

Get full-text (via PubEx)

A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2007.01284.x ◽

2007 ◽

Vol 61 (3) ◽

pp. 403-410 ◽

Cited By ~ 8

Author(s):

L. W. Chu ◽

P. Y. Yik ◽

W. Mok ◽

C. P. Chung

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Hong Kong ◽

Open Label ◽

Open Label Study ◽

Label Study

Get full-text (via PubEx)

Gait Changes with Anti-Dementia Drugs: A Prospective, Open-Label Study Combining Single and Dual Task Assessments in Patients with Alzheimer’s Disease

Drugs & Aging ◽

10.1007/s40266-014-0175-3 ◽

2014 ◽

Vol 31 (5) ◽

pp. 363-372 ◽

Cited By ~ 13

Author(s):

Olivier Beauchet ◽

Cyrille P. Launay ◽

Gilles Allali ◽

François R. Herrmann ◽

Cedric Annweiler

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Dual Task ◽

Open Label ◽

Open Label Study ◽

Label Study

Get full-text (via PubEx)

EFFECTIVENESS AND TOLERABILITY OF SOUVENAID IN CHINESE PATIENTS WITH MILD ALZHEIMER’S DISEASE AND OTHER DEMENTIAS IN A REAL-WORLD CLINIC SETTING: AN OPEN-LABEL STUDY

Alzheimer s & Dementia ◽

10.1016/j.jalz.2017.06.1814 ◽

2017 ◽

Vol 13 (7) ◽

pp. P930 ◽

Cited By ~ 1

Author(s):

Leung Wing Chu ◽

Alzheimer’s Disease Research Network

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Real World ◽

Chinese Patients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Clinic Setting

Get full-text (via PubEx)